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We investigated the contribution of human platelets
to macrophage effector properties in the presence
of lipopolysaccharide (LPS), as well as the beneficial
effects and time frame for platelet transfusion in sep-
tic animals. Our results show that platelets sequester
both pro-(TNF-a/IL-6) and anti-(IL-10) inflammatory
cytokines released by monocytes. Low LPS concen-
trations (0.01 ng/mL) inducedM2macrophage polar-
ization by decreasing CD64 and augmenting CD206
and CD163 expression; yet, the presence of platelets
skewed monocytes toward type 1 macrophage (M1)
phenotype in a cell-contact-dependent manner by
the glycoprotein Ib (GPIb)-CD11b axis. Accordingly,
platelet-licensed macrophages showed increased
TNF-a levels, bacterial phagocytic activity, and a
reduced healing capability. Platelet transfusion
increased inducible nitric oxide synthase (iNOS)+
macrophages, improving bacterial clearance and
survival rates in septic mice up to 6 h post-infection,
an effect that was abolished by CD11b and
GPIb blockade. Our results demonstrate that plate-
lets orchestrate macrophage effector responses,
improving the clinical outcome of sepsis in a narrow
but relevant time frame.INTRODUCTION
Beyond their critical role in hemostasis, platelets can regulate
inflammation and infection through multiple mechanisms. Plate-
lets may act as sentinels in the circulation, rapidly bind blood-
borne pathogens, and activate several mechanisms that control
innate resistance to infection (Semple, Italiano and Freedman,
2011; Kapur et al., 2015; Kapur and Semple, 2016). Platelets ex-
pressmajor innate immune-relatedmolecules, including Toll-likeThis is an open access article under the CC BY-N
CELREPreceptors (TLRs), complement receptors, adhesion molecules,
and mediators essential for recruiting neutrophils and mono-
cytes (Kral et al., 2016; Li, Zarbock and Hidalgo, 2017). Although
lipopolysaccharides (LPSs) have limited effects on platelet acti-
vation, platelet-derived TLR4 appears to be critical for sensing
LPS levels and promoting interactionwith neutrophils andmono-
cytes (Deppermann and Kubes, 2016).
Whereas platelet interactions with monocytes-macrophages
play a relevant role in response against bacterial infections, it re-
mains unclear whether this interaction is beneficial or harmful for
the host. In vitro studies are limited and controversial, showing
the inhibition or induction of either pro- or anti-inflammatory cy-
tokines during co-culture of platelets with monocytes-macro-
phages followed by stimulation with LPS (Scull, Hays and
Fischer, 2010; Gudbrandsdottir, Hasselbalch and Nielsen,
2013; Xiang et al., 2013). Furthermore, in vivo studies also
showed controversial results. Although formation of circulating
platelet-monocyte aggregates appears to amplify the inflamma-
tory response and predicts mortality in older septic patients
(Rondina et al., 2015), several studies have demonstrated that
platelets contribute to bacterial clearance and resolution of
inflammation by regulating macrophage responses (Xiang
et al., 2013; de Stoppelaar et al., 2014; Wuescher, Takashima
andWorth, 2015; Ali et al., 2017). In this sense, in a murine model
of septic shock induced by intraperitoneal injection of bacteria,
platelets inhibit the release of macrophage-derived pro-inflam-
matory molecules and rescue mice from death, highlighting the
beneficial therapeutic role of platelets in severe septic patients
(Xiang et al., 2013). However, given the differences between
mouse and human macrophages, the biological relevance of
platelet-macrophage interactions to human innate immunity re-
mains uncertain.
Depending on prevalent stimuli in inflammatory microenviron-
ments, human macrophages can be differentiated from
circulating monocytes in vitro and polarized toward pro- or
anti-inflammatory macrophages (typically recognized as
classically activated-type 1 macrophage (M1) and alternatively
activated-M2 macrophages, respectively). Microbes, damaged
tissues, as well as the tissue microenvironment shapeCell Reports 28, 1–13, July 23, 2019 ª 2019 The Authors. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lighting the plasticity of this process. This plasticity is critical
for the initiation and resolution of the inflammatory response
(Martinez and Gordon, 2014; Murray et al., 2014; Murray, 2017).
The biology ofmacrophage differentiation and polarization has
mainly focused on soluble stimuli (such as cytokines and TLR
ligands); however, the influence of cellular interactions in macro-
phage reprogramming has been poorly explored. In this regard,
co-culturing humanmonocytes with regulatory T cells skews the
balance toward differentiation of M2 macrophages (Tiemessen
et al., 2007). Moreover, a recent study demonstrated that
apoptotic cells are key players in the acquisition of anM2 pheno-
type when exposed to interleukin-13 (IL-13) and IL-4 (Bosurgi
et al., 2017).
We hypothesized that platelets may skew the monocyte pro-
gram toward a pro-inflammatory M1 phenotype in the presence
of LPS, a key point to restrict bacterial dissemination, and that
cell-contact-dependent crosstalk is critical for inducing the
effector response. To further understand the role of platelets un-
der septic conditions, we performed platelet transfusions at
different time points after infection and evaluated outcomes in in-
fected mice, as well as bacterial clearance and macrophage re-
sponses. The present work provides new insights into platelet
biology, highlighting the role of these cells in promoting leuko-
cyte reprogramming and enhancing immunity during critical
life-threatening infections such as those associated with sepsis.
RESULTS
Platelets Sequester Both Pro- and Anti-inflammatory
Cytokines Released by Monocytes
Human platelets were co-culturedwith sorted CD14+monocytes
and stimulated with LPS for 24 and 48 h to evaluate the pro-in-
flammatory cytokines tumor necrosis factor alpha (TNF-a) and
IL-6 and the anti-inflammatory cytokine IL-10, respectively.
Monocyte stimulation with LPS (0.0001–1 ng/mL) resulted in a
significant release of TNF-a, IL-6, and IL-10, whereas no cyto-
kines were observed in LPS-stimulated platelets (Figures 1A–
1C). The presence of platelets in the co-culture significantly
reduced the amount of TNF-a and IL-6 released (Figures 1A
and 1B). Surprisingly, we also observed that platelets signifi-
cantly dampened IL-10 levels (Figure 1C), suggesting that
cytokine reduction by platelets is not selective for pro- or anti-in-
flammatory mediators. Given that monocytes are the main
source of cytokines after LPS stimulation and that they did not
show significant differences in cell death after culture in the pres-
ence or absence of platelets (83.08% ± 4.48% versus 81.67% ±
4.53% of viable cells respectively), we first evaluated if platelets
induced an alteration of cytokine synthesis in monocytes. The
intracellular levels of TNF-a in monocytes, after 24 h of LPS stim-
ulation, was similar regardless of whether monocytes had been
co-cultured in the absence or presence of platelets (Figures 1D
and S1A). We then sought to examine the possibility that plate-
lets could sequester cytokines released by LPS-stimulated
monocytes. Platelets were removed from the 24-h co-culture
by fast washing with 10 mM EDTA buffer, and intracellular
TNF-a was determined in platelets by flow cytometry. As shown
in Figure 1E, TNF-a was detected inside platelets that had been2 Cell Reports 28, 1–13, July 23, 2019
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platelets were loading cytokines (see Figure S1B for gating strat-
egy). This observation was confirmed by analyzing cytokine
localization in the 24-h co-culture of platelets and LPS-stimu-
lated monocytes by confocal microscopy. Figure 1F shows
co-localization images of the platelet-specific marker CD41
and cytokines (TNF-a, IL-6, and IL-10). The observation that
the addition of platelets even at later time points reduced the
amount of cytokines in supernatants of co-cultures indicated
that reduction of cytokines was not due to platelet scavenging
of LPS (Figure S1C).
Platelets Polarize Monocytes toward M1 Pro-
inflammatory Profile in the Presence of LPS
Pro-inflammatory (M1) macrophages, characterized by the
secretion of pro-inflammatory cytokines, high expression of
CD64, and low expression of CD206 and CD163, are responsible
for pathogen phagocytosis and killing. Anti-inflammatory (M2)
macrophages, which are involved in tissue repair and provide
regulatory signals, express high levels of CD206 and CD163
and lower levels of CD64 antigens (Martinez and Gordon,
2014). Given the functional relevance of these macrophage
populations, we evaluated whether platelets could modulate dif-
ferentiation, polarization, and function of monocyte-derived
macrophage (M-DM) after 5 days co-culture in the presence of
a broad range of LPS concentrations. Interestingly, stimulating
monocytes with very low LPS concentrations (0.0001–
0.01 ng/mL) induced differentiation to M2 macrophages by
decreasing CD64 and augmenting CD206 and CD163 expres-
sion levels. In contrast, a highly pronounced pro-inflammatory
M1 phenotype was observed when cells were exposed to
increasing LPS concentrations (Figures 2A–2D). Remarkably, in
the presence of platelets, monocytes were predominantly polar-
ized toward the M1 phenotype, independent of LPS concentra-
tions, by upregulating CD64 and decreasing CD206 and CD163
expression (Figures 2A–2D). Moreover, AXL and MERTK, which
are tyrosine kinase receptors that are differentially expressed in
pro-inflammatory M1 versus anti-inflammatory M2 macro-
phages (Zago´rska et al., 2014), showed a clear dichotomous
expression pattern, as in the presence of platelets and LPS,
macrophages predominantly expressed AXL, thus reinforcing
the notion that platelets polarize monocytes toward the M1
macrophage phenotype (Figure 2E).
To determine whether phenotypic changes in monocytes-
platelet-derived macrophages (M/P-DM) correlated with the
expected functions, intracellular TNF-a production and GFP-
Escherichia coli phagocytosis assays were performed. Classical
M1 responses and the healing response of human umbilical vein
endothelial cells (HUVECs) challenged with conditioned media
from platelet-inducedmacrophages were assessed as a readout
of the anti-inflammatory M2 response. We observed that stimu-
lation of CD14+ monocytes with 0.01 ng/mL of LPS for 5 days
induced a macrophage phenotype characterized by the produc-
tion of intermediate levels of TNF-a (Figure 2F), with a lower ca-
pacity of bacterial phagocytosis but increased wound-healing
properties, consistent with an M2 phenotype (Figures 2G and
2H). However, in the presence of platelets and LPS, macro-
phages showed significantly higher production of intracellular2
Figure 1. Platelets Decrease Pro- and Anti-inflammatory Cytokines Released by Monocytes
(A–C)Monocyteswere stimulated with different concentrations of LPS in the presence or absence of platelets. Pro-inflammatory (A) TNF-a and (B) IL-6 and the (C)
anti-inflammatory cytokine IL-10 were measured in the supernatants after 24 and 48 h of co-culture, respectively.
(D) Intracellular levels of TNF-a were analyzed in monocytes by flow cytometry after 24 h of co-culture.
(E) After 24 h of culture, platelets were harvested from the co-culture by adding 10 mM EDTA, stained with a PE-conjugated Ab against TNF-a, and analyzed by
flow cytometry.
(F) The specific platelet marker CD41 (red) and the pro-inflammatory TNF-a and IL-6 and anti-inflammatory IL-10 (cyan) cytokines were analyzed by confocal
microscopy after 24 h of monocyte + platelet co-culture. Representative images (603, zoom 33) of platelet and cytokine staining, co-localization, and differential
interference contrast (DIC) of co-culture are shown (scale bar: 10 mm).
Independent data from each experiment, n = 4–6. Two-way ANOVA using the Fisher least significant difference (LSD) test, one-way ANOVA with the Tukey
multiple comparison test, or two-tailed paired Student’s t test were used. Statistical significance was set at p < 0.05. *p < 0.05. Data are represented as
mean ± SEM.
See also Figure S1.
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Figure 2. Platelets Polarize Monocytes to Pro-inflammatory Macrophages
Monocytes were cultured in the presence or absence of platelets and stimulated with different concentrations of LPS for 5 days to obtain monocyte-derived
macrophages (M-DM) and monocyte-platelet-derived macrophages (M/P-DM).
(A) Representative dot plot showing CD64 versus CD206 and CD163 versus CD206, after gating on viable cells and CD11b+ macrophages, are shown.
(B–D) The percentages of (B) CD64+CD206, (C) CD206+CD64, and (D) CD206+CD163+ cells are graphed.
(E) Representative levels of AXL and MERTK expression in macrophages are shown.
(F) Macrophage intracellular levels of TNF-a were analyzed by flow cytometry, and the percentage of positive cells after 5 days of co-culture is graphed.
(G) Macrophage phagocytosis of E. coli-GFP was assessed, and the cells were analyzed by flow cytometry. The percentages of GFP-positive cells are shown.
(H) After 5 days of macrophage differentiation in the presence or absence of platelets and LPS, the cells were re-stimulated with phorbol 12-myristate 13-acetate
(PMA; 50 nM) for 1 h, and the supernatant was used to stimulate confluent HUVEC monolayers that had been scratched. Cell migration into the scratched area
was calculated by analyzing images with ImageJ software at 0 and 6 h. Representative images (43) of the kinetics of gap closure. (scale bar: 200 mm).
Independent data from each experiment, n = 6–10. Two-way ANOVA using the Fisher LSD test and one-way ANOVAwith the Tukeymultiple comparison test were
used. Statistical significance was set at p < 0.05. *p < 0.05. Data are represented as mean ± SEM.
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Figure 3. Platelet-Mediated Polarization of M1 Macrophages Is Dependent on Cell-Cell Contact and the GPIb-CD11b Partnership
(A–E) A transwell system was used to evaluate cell contact dependency.
(A–C) The percentage of (A) CD64+CD206, (B) CD206+CD64, and (C) CD206+CD163+ cells revealed phenotype characterization.
(D and E) Percentage of E. coli phagocytosis (D) and percentage of gap closure (E) revealed functional assays of macrophage differentiated in the presence or
absence of platelets (M/P-DM and M-DM, respectively) and 0.01 ng/mL of LPS.
(F–J) An isotype IgG control, blocking Abs against glycoprotein (GP)Ib and CD11b, or eptifibatide was added to the co-culture, and phenotype phenotype
(CD64+ in F; CD206+ in G; CD206+CD163+ in H) and functional (phagocytosis in I and Gap closure in J) analyses were performed at day 5.
Independent data from each experiment, n = 6. One-way ANOVA with the Tukey multiple comparison test was used. Statistical significance was set at p < 0.05.
*p < 0.05. Data are represented as mean ± SEM.
See also Figures S2 and S3.
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ability to induce endothelial wound healing (Figures 2F–2H),
which typically delineates an M1 signature.
Platelet-Mediated Polarization of M1 Macrophages Is
Dependent on Cell-Cell Contact and the Glycoprotein Ib
(GPIb)-CD11b Partnership
Cell-contact dependency was first determined using a Transwell
system. When platelets and monocytes were physically sepa-
rated, phenotypic and functional M1 polarization was eliminated
even in the presence of LPS, (Figures 3A–3E). CD41+ positive
platelets, attached to the surface or located inside of mono-
cytes-macrophages were evaluated after 12, 24, 48, 72, andCELREP96 h of initial co-culture. We observed that 40%–60% of mono-
cytes had surface-bound or internalized platelets during the first
24 h (Figure S2A). Remarkably, when platelets were removed
from co-culture after 24 h washing, M1 macrophage polarization
still occurred. This result highlights the relevance of an early
engagement of amacrophage differentiation program by platelets
(Figure S2B). Furthermore, adding platelets 24 or 48 h after mono-
cytes started differentiation was not effective in tilting the balance
toward macrophage M1 polarization, suggesting that differentia-
tion was already in progress (Figure S2C). These results reinforce
our hypothesis that the initial contact betweenplatelets andmono-
cytes is critical for defining the fate of monocyte-macrophage dif-
ferentiation and polarization reprogramming.Cell Reports 28, 1–13, July 23, 2019 5
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Figure 4. Platelet-Mediated Polarization of
M1 Macrophages Is Tempered by Tyrosine
Kinase TYRO3 and AXL Receptors
(A–E) Monocytes were pre-treated with Abs against
AXL or TYRO3 or both and then co-incubated
with platelets. Additionally, recombinant annexin V
was added into the co-culture to block
PtSer. Phenotype analysis revealed the percent-
ages of (A) CD64+CD206, (B) CD206+CD64, and
(C) CD206+CD163+ cells, and functional assays re-
vealed (D) the percentage of E. coli phagocytosis
and (E) the percentage of gap closure after 5 days of
macrophage differentiation in the presence or
absence of platelets (M/P-DM and M-DM, respec-
tively) and 0.01 ng/mL of LPS. (n = 6).
One-way ANOVA using the Fisher LSD test
was performed. Statistical significance was set at
p < 0.05. *p < 0.05. Data are represented as
mean ± SEM.
See also Figure S4.
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then evaluated the role of glycoprotein (GP) Ib and integrin
aIIbb3, two of the major platelet surface receptors. Polarization
of monocytes toward the M1 phenotype was prevented when
co-culture was performed in the presence of an anti-GPIb-block-
ing monoclonal antibody (mAb) but not when eptifibatide (integ-
rin aIIbb3 antagonist) was used (Figures 3F–3J). Considering that
CD11b is a counter-receptor for GPIb (Simon et al., 2000), we
then investigated the role of this molecule in macrophage polar-
ization. Blocking CD11b completely prevented the switch to-
ward M1 macrophages (Figures 3F–3J). Taken together, these
results highlight the role of the GPIb-CD11b axis in platelet-
mediated macrophage polarization.
Cell-contact dependency does not preclude a role for soluble
factors after association occurs. Because LPS triggers the acti-
vation of both platelet cyclooxygenase (COX) and platelet factor
4 (PF4) (Carestia et al., 2016), we next evaluated the role of these
pathways in the induction of the M1 program. We used aspirin-
treated platelets, which were washed before co-culture to inhibit
COX and heparin to block PF4 activity during the co-culture. Re-
programming of platelet-induced monocyte polarization toward
the M1 phenotype was not altered by inhibition of platelet COX
(Figures S3A–S3E). However, induction of a pro-inflammatory
macrophage program during the co-culture was partially
reversed by using heparin (Figures S3A–S3E). Furthermore, the
partial role of platelet PF4 in the induction of an M1 macrophage6 Cell Reports 28, 1–13, July 23, 2019
CELREP 6522phenotypewas confirmed using a blocking
antibody (Ab) against PF4 (Figures S3F–
S3H).
TAM Receptors Regulate Platelet-
Mediated Macrophage M1
Polarization
TYRO3, AXL, and MERTK (TAM) are key
negative regulatory players in innate cells
activated by two endogenous ligands: pro-
tein S (PROS1) and growth-arrest-specific6 (GAS6). Phosphatidylserine (PtSer) exposure is crucial for
TAM-ligand engagement (Rothlin et al., 2015), and this pathway
has been shown to be critical in macrophage polarization (Bo-
surgi et al., 2017). For this reason and given that platelets contain
PROS1 and expose PtSer after activation as shown in Figure S4
and in previous studies (Bevers, Comfurius and Zwaal, 1983;
Schwarz et al., 1985) and monocytes express mainly AXL and
TYRO3, we evaluated this negative regulatory signal by blocking
both receptors. Simultaneous inhibition of both AXL/TYRO3 re-
ceptors enhanced the M1 macrophage signature (Figures 4A–
4E). Furthermore, adding annexin V, a competitor of PROS1 for
PtSer binding, from the initiation of co-culture, recapitulated
the phenotype observed after AXL and TYRO3 blockade (Figures
4A–4E).
Platelet TransfusionsProtectMice fromSeptic Shock by
Inducing Inducible Nitric Oxide Synthase (iNOS)+
Macrophages
Having demonstrated that platelets reprogram monocytes to-
ward the M1 pro-inflammatory phenotype, we hypothesized
that platelet transfusion might be beneficial at early time points
during sepsis development by promoting monocyte skewing to-
ward the M1 phenotype. To address this issue, a sepsis model
was induced by intraperitoneal (i.p.) injection of 1 3 109 GFP-
E. coli in male C57BL/6J mice. As expected, infected animals
showed thrombocytopenia as early as 2 h post-infection (hpi),
Figure 5. Platelet Transfusion Protects Mice from Septic Shock by Inducing iNOS+ Macrophages
Septic shock was induced in male C57BL/6 mice by i.p. injection of 1 3 109 E. coli, and the mice were monitored for 48 h.
(A) Platelet numbers were measured at different time points after infection.
(B) Survival curves of mice infected with E. coli (n = 15), and mice infected with E. coli plus a platelet transfusion immediately, indicated as 0 (n = 12), or 2 (n = 9),
6 (n = 9) or 12 (n = 4) hpi. Non-infected animals (n = 4) and animals that received only the platelet transfusion (n = 4) are indicated as a control.
(C–F) Representative dot plots of spleen CD11b/F4-80 subpopulations are shown after gating on live cells. The percentages of iNOS+ and arginase+ cells (C) were
analyzed in the (D) CD11bhighF4-80high, (E) CD11bhighF4-80low, and (F) CD11bnegF4-80high subpopulations. Representative dot plot of iNOS versus arginase in
each subpopulation and independent data are shown. The fluorescence minus one (FMO) controls of iNOS and arginase were used to set the threshold.
(G) The percentage of CD206+ cells in the spleen CD11bhighF4/80high population is shown.
(legend continued on next page)
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and a significant reduction of circulating lymphocytes (Figures
5A and S5A). Multi-organ failure was confirmed by measuring
plasma concentrations of alanine aminotransferase enzymes
(ALTs) and aspartate aminotransferase enzymes (ASTs), lactate
dehydrogenase (LDH), and creatine kinase, which were signifi-
cantly increased in the plasma of septic mice, indicating tissue
damage and organ dysfunction (Figure S5C). Histo-pathological
analysis of liver and lung confirmed the clinical findings (Fig-
ure S6D). At 12 hpi, animals started to die, reaching more than
80% mortality at 48 hpi (Figure 5B). To determine whether
platelet transfusion ameliorates septic shock, washed platelets
(0.25 3 109 per mouse) were infused by retro-orbital injection
immediately or 2 h, 6 h, or 12 h after E. coli infection. Efficiency
of platelet transfusion was determined by injecting carboxyfluor-
escein succinimidyl ester (CFSE)-labeled platelets and analyzing
the percentage of labeled platelets in circulation at different time
points after transfusion by flow cytometry (Figure S5B). Remark-
ably, platelet transfusions increased mice survival not only when
performed immediately but also when given 2 or 6 h after E. coli
infection (60%) compared with infected animals not receiving
platelet transfusions (20%) (Figure 5B).
To confirm the hypothesis that platelet transfusion induces pro-
inflammatorymacrophages, iNOS and arginasewere evaluated in
three spleen subpopulations, namely, CD11bhigh/F4-80low,
CD11bhigh/F4-80high, and CD11bneg/F4-80high, in infected animals
(Figure 5C). Notably, transfusion of platelets performed immedi-
ately, 2,or6hpi increased thepercentagesof iNOS+macrophages
in the three cell subpopulations studied without changes in argi-
nase expression (Figures 5D–5F). We also observed that platelet
transfusion increased CD206+ cells in the CD11bhigh/F4-80high
spleen macrophage subpopulation (Figure 5G), suggesting the
onset of the resolution process. Of note, a similar increase in
iNOS+ cells in the CD11bhigh/F4-80high subpopulation was
observed in transfused non-infected animals (Figures 5D–5G).
Furthermore, infectedmice that received a platelet transfusion
showed reducedpercentages ofGFP+E. colibacteria (Figure 5H)
and patrolling pro-inflammatory monocytes (CD11b+Ly6C+) in
the peripheral blood (Figure 5I).
Then, we aimed to confirm the effects of platelets in macro-
phage polarization by using another model of sepsis. We
observed that the high-grade sepsis model induced by cecal
ligation puncture (CLP) reached 80% mortality after 5 days of
surgical procedure, and a significant increased survival rate
was observed after platelet transfusions (Figure S6A). Addition-
ally, a significant drop in platelets number was observed in
CLP animals compared to controls and CLP plus platelets (Fig-
ure S6B). Furthermore, mice receiving platelets augmented the
percentage of spleen pro-inflammatory F4/80highCD11bhigh/low
iNOS+M1macrophages compared to CLP and controls (Figures
S6C and S6D).(H and I) The percentages of GFP-positive cells in the blood (H) and CD11b+Ly6C
Meier method, followed by the log-rank test.
One-way ANOVA with the Fisher LSD test was performed to compare E. coli-inf
Statistical significances are indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.
Survival curve: &p < 0.05 versus control; #p < 0.05 and ##p < 0.01 versus E. col
See also Figures S5 and S6.
8 Cell Reports 28, 1–13, July 23, 2019
CELREP 652Our data indicate that platelet transfusion during sepsis in-
duces a pro-inflammatory macrophage program that facilitates
clearance of bacterial load and results in an increased survival
rate.
In Vivo Blockade of CD11b or Platelet GPIb Suppresses
the Protective Effect of Platelet Transfusion in
Septic Mice
Finally, we evaluated the in vivo relevance of CD11b/GPIb inter-
actions between myeloid cells and transfused platelets to the
observed increased survival rate of septic mice by using two
different strategies. First, we treated mice with anti-CD11b Ab
prior to infection and then masked GPIb molecules in washed
platelets prior to transfusion. Blocking CD11b 1 h prior to infec-
tion and platelet transfusion significantly reduced the survival
rate of infected animals that received platelets (Figure 6A). Simi-
larly, blocking GPIb on platelets before transfusion also
decreased the survival rate of septic animals (Figure 6A). Further-
more, a significant increase in bacteraemia was observed
after blocking both molecules (Figure 6B), and a significant
reduction in iNOS+ cells was detected in splenic F4-80/CD11b
macrophage when either CD11b or GPIb were blocked (Figures
6C–6D).
DISCUSSION
In this study, we have demonstrated that platelets regulate the
inflammatory monocyte response by sequestering both pro-
and anti-inflammatory cytokines and reprogrammingmonocytes
toward the M1 phenotype. Moreover, the transfusion of platelets
at the beginning of the E. coli-induced sepsis model reduced
mortality by increasing iNOS expression and bacterial clearance.
Although previous studies mostly used platelets activated by
classical agonists, such as collagen, thrombin, or adenosine
diphosphate (ADP) (Weyrich et al., 1996; Halvorsen et al.,
2014; Vogel et al., 2016; Linke et al., 2017; Pierre et al., 2017),
scarce data have been documented regarding platelet-mono-
cyte interaction after LPS stimulation. Xiang et al. (2013) recently
showed that platelets reduce TNF-a production bymurine bone-
marrow-derived macrophages at high LPS concentrations
(1 ng/mL) and that platelets induce an anti-inflammatory
response in murine macrophages. Here, we show that platelets
reduced not only TNF-a but also IL-6 and IL-10 in human platelet
monocytes co-cultured in the presence of a broad range of LPS
concentrations. Intriguingly, we observed that cytokine reduc-
tionwas due to platelet sequestration ofmonocyte-derived cyto-
kines. In fact it has been long recognized that platelets can load
plasma molecules (Banerjee and Whiteheart, 2017) and can
selectively take up angioregulatory proteins in microscopic
tumors (Klement et al., 2009). Furthermore, it has been
recently shown that platelets can be loaded with ADAMTS-13+ patrolling monocytes (I) are shown. Survival was compared using the Kaplan-
ected mice and infected animals that had also received a platelet transfusion.
i. Data are represented as mean ± SEM.
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type 1 motif,13) for release upon activation (Abdelgawwad
et al., 2018).It remains to be determined, whether, like
ADAMTS-13, platelet-sequestered monocyte-derived cytokines
upon LPS stimulation can be released at a distal site in vivo.
Remarkably, platelets also reprogrammed monocytes toward
theM1 pro-inflammatory phenotype in a cell-contact-dependent
manner (GPIb-CD11b partnership) and independently of the pro-
inflammatory cytokine milieu, indicating that cytokine scav-
enging and macrophage polarization are two independent
platelet-mediated regulatory effects on monocyte-macrophage
biology. In mice, platelet GPIba engages integrin Mac-1 to
orchestrate monocyte differentiation signals through the fork-
head transcription factor FOXP1 (Shi et al., 2004, 2008; Wang
et al., 2017), and platelets can encase bacteria through a mech-
anism that involves ‘‘touch-and-go’’ between GPIb and von Wil-
lebrand factor expressed on Kupffer cells in the liver sinusoids
(Wong et al., 2013). This platelet surveillance mechanism has
been proposed to contribute to rapid host defense and early sur-
vival against certain blood-borne pathogens. Our data highlight
an alternative strategy through which platelets may contribute
to rapid bacterial clearance.
It has been shown that PF4 controlsmonocyte survival and dif-
ferentiation (Scheuerer et al., 2000) as well as the induction of a
distinct subtype of macrophages termed M4 (Gleissner, 2012)
and that platelet-derived PGE2 can regulate monocyte inflam-
matory responses (Xiang et al., 2013; Linke et al., 2017). How-
ever, our data indicate that PF4 is required only to some extent
to trigger platelet-mediated M1 reprogramming and aspirin-
treated platelets did not trigger changes in M1 macrophage po-
larization. Importantly, these discrepancies could be related to
mouse and human differences. In addition, although most
studies on human platelets show that LPS has no direct effect
in vitro but can synergise with other platelet agonists (Rivade-
neyra et al., 2014; Vallance et al., 2017), monocytes are highly
sensitive to LPS. Hence, we speculated that monocytes may
trigger cross-activation of platelets, enabling a bi-directional
synergism that might induce the synthesis and/or release of
additional soluble factors that still remain elusive.
Interestingly, we also found that the AXL and TYRO3 tyrosine
kinase receptors, which are involved in the control of innate im-
munity, negatively regulated platelet-mediated monocyte polar-
ization to pro-inflammatory macrophages. Of note, this effect
appears to play a major role during the initial monocyte contact
because blocking Abs were washed away before co-culture to
avoid any effect on platelets. The observation that administration
of recombinant Gas6 in a murine sepsis model results in lowerFigure 6. In Vivo Blocking of CD11b or Platelet GPIb Suppress the Pro
Septic shock was induced in male C57BL/6 mice by i.p. injection of 1 3 109 E. c
(A) Survival curve of septic mice after blocking CD11b molecule 1 h previous to th
transfusion, washed, and then transfused.
(B) Bacteremia was analyzed as the percentage of GFP+ cells in blood.
(C) Representative dot plots showing iNOS and arginase expression after gating in
macrophage subpopulations.
(D) Independent data showing the percentage of INOS+ or arginase+ are grap
intravenously (i.v.) or platelets treated with isotype were used as controls. Surviva
One-way ANOVA with the Fisher LSD test was used, and statistical significance i
##p < 0.01 versus E. coli + platelets. Data are represented as mean ± SEM.
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to endotoxin shock (Giangola et al., 2013; Rothlin et al., 2015)
supports the relevance of this pathway in sepsis. However,
because the expression of these receptors changes during
macrophage differentiation, further studies are necessary to
deeply understand the TAM pathway during platelet-induced
macrophage polarization.
In two different mousemodels of sepsis (bacterial infusion and
CLP), we showed that platelet transfusions significantly reduced
animal mortality in a specific time frame. This information could
be extremely relevant for clinical application, given the window
through which platelet transfusion may be beneficial for patients
with sepsis.
Interestingly, increased animal survival induced by platelet
transfusion was previously ascribed to platelet-dependent inhi-
bition of macrophage-mediated inflammatory response (Xiang
et al., 2013). In contrast, our data suggest that the beneficial ef-
fect of platelet transfusion is due to an increase in iNOS+ macro-
phages, which contribute to efficient bacterial clearance.
There is a growing appreciation for the contribution of platelets
to immunity, and it was demonstrated that mouse platelets
enhance phagocytosis and killing capacity against bacteria (Ali
et al., 2017; Kraemer et al., 2011; Hamzeh-Cognasse et al.,
2015). Additionally, allogeneic platelet transfusion can induce
potent antibody-dependent immunity in mice, dependent on
iNOS and interferon (IFN)-g (Semple et al., 1995; Bang et al.,
2000; Sayeh et al., 2004). Likewise, circulating immune com-
plexes allow platelets to live longer and recirculate after degran-
ulation, playing a critical role as mediators of the inflammatory
response (Cloutier et al., 2018). Supporting experimental
studies, a consortium report has shown that admission thrombo-
cytopenia is associated with enhanced mortality and a more
disturbed host response during sepsis independently of disease
severity (Claushuis et al., 2016).
Notably, we found that the positive effect of platelet transfu-
sion was limited to a narrow time window, reinforcing the notion
that platelets play a protective role in sepsis during early stages
of the host response to infection when inflammatory stimuli are
still low. In addition, our findings suggest that the persistence
of platelet-mediated M1 macrophage differentiation would be
harmful to the host.
Beyond their central roles in hemostasis and thrombosis,
platelets are now acknowledged as essential players during
infection, which disrupt tissue integrity and contribute to inflam-
mation, pathogen killing, and tissue repair (Koupenova et al.,
2018). This progress has opened a new perspective in our under-
standing of sepsis pathophysiology (Dewitte et al., 2017). Thus,tective Property of Platelet Transfusions in Septic Mice
oli, and the mice were monitored for 48 h.
e infection and platelet transfusion. Platelets GPIb was blocked 30 min before
the three spleenCD11bhighF4-80high, CD11bhighF4-80low, and CD11b-F4-80high
hed for each subpopulation. Animals receiving the same amount of isotype
l was compared using the Kaplan-Meier method, followed by the log-rank test.
s indicated as *p < 0.05, **p < 0.01, and ***p < 0.001. Survival curve: #p < 0.05,
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vival of Septic Mice, Cell Reports (2019), https://doi.org/10.1016/j.celrep.2019.06.062the function of platelets extends beyond direct encounters with
pathogens. Our findings identify a central role of platelet-mono-
cyte interactions, which can occur intra- and extravascularly, in
reprogramming phagocytic cells, thus fostering antimicrobial
function during sepsis. These findings may have implications in
other blood-associated infections and a wide range of patho-
physiologic conditions, including sepsis, chronic inflammation,
atherosclerosis, and cancer.
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Dylight 649 Streptavidin BioLegend Cat# 405224
Alexa Fluor 488 Donkey anti-Rabbit IgG clone Poly4064 BioLegend Cat# 406416; RRID:AB_2563203
Biotin rat anti-human IL-6 clone MQ2-39C3 BioLegend Cat# 501202; RRID:AB_2249232
Purified mouse anti-human CD42b (GPIb) clone HIP1 BioLegend Cat# 303902; RRID:AB_314382
PerCP/Cy5.5 rat anti-mouse/human CD11b clone M1/70 BioLegend Cat# 101227; RRID:AB_893233
APC/Cy7 rat anti-mouse F4/80 clone BM8 BioLegend Cat# 123117; RRID:AB_893489
Alexa Fluor 647 rat anti-mouse CD206 clone C068C2 BioLegend Cat# 141712; RRID:AB_10900420
PE Mouse IgG1 k Isotype Ctrl clone MOPC-21 BioLegend Cat# 400140; RRID:AB_493443
Purified Annexin V BioLegend Cat# 640902; RRID: AB_2562279
LEAF Purified rat anti-mouse/human CD11b clone M1/70 BioLegend Cat# 101214; RRID: AB_312797
PE sheep anti-human/mouse Arginase 1 R&D Systems Cat# IC5868P
APC mouse anti-human MERTK clone 125518 R&D Systems Cat# FAB8912A; RRID:AB_357213
Biotin goat anti-human AXL R&D Systems Cat# BAF154; RRID:AB_2062559
Goat anti-human AXL R&D Systems Cat# AF154; RRID:AB_354852
Goat anti-human TYRO3/DKT R&D Systems Cat# AF859; RRID:AB_355666
Normal Goat IgG control R&D Systems Cat# AB-108-C; RRID:AB_354267
Normal Goat IgG Biotinylated Control R&D Systems Cat# BAF108; RRID:AB_355828
Rabbit anti-human/mouse TYRO3 Novus Biologicals Cat# NBP1-28635; RRID:AB_1914103
Mouse anti-human CD42b (GP1b) clone VM16d Novus Biologicals Cat# NBP1-42151; RRID:AB_2113946
Rabbit IgG1 anti-human PF4 Abcam Cat# ab9561; RRID:AB_308720
FITC rat anti-human PROS1 clone PS7 Abcam Cat# ab81713; RRID:AB_1640157
Rat IgG2a (RTK2758) FITC Isotype control Abcam Cat# ab18446
Biotin rat IgG2a anti-human IL-10 clone JES3-12G8 eBioscience Cat# 13-7109; RRID:AB_466921
PE/Cy7 rat anti-mouse iNOS clone CXNFT eBioscience Cat# 25-5920-82; RRID:AB_2573499
Rat IgG2b anti human/mouse CD11b clone 5C6 Fisher Scientific Cat# PIMA-516527; RRID:AB_2538032
Bacterial and Virus Strains
E. coli DH5a GFP tagged Ricardo Martı´n Go´mez N/A
Chemicals, Peptides, and Recombinant Proteins
BD Cytofix/Cytoperm BD Biosciences Cat# 554714
BD GolgiStop BD Biosciences Cat# 554724
eBioscience Fixable Viability Dye eFluor 780 Invitrogen Cat# 65-0865-14
eBioscience Fixable Viability Dye eFluor 450 Invitrogen Cat# 65-0863-14
eBioscience CFSE Invitrogen Cat# 65-0850-84
Ficoll-Paque PLUS GE Healthcare - Life Sciences Cat# 17144003
Lipopolysaccharides from Escherichia coli O111:B4 (LPS) Sigma-Aldrich Cat# L3024
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Ionomycin from Streptomyces conglobatus Sigma-Aldrich Cat# I9657
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich Cat# P1585
Heparin sodium salt Sigma-Aldrich Cat# H3149
Acetylsalicylic acid (Aspirin) Sigma-Aldrich Cat# A5376
2,2,2-Tribromoethanol (Avertin) Sigma-Aldrich Cat# T48402
Gelatin from bovine skin Sigma-Aldrich Cat# G-9391
Paraformaldehyde Powder Cicarelli Cat# 1088211
Penicillin-Streptomycin GIBCO Cat# 15-140-122
Fetal Bovine Serum, qualified, New Zealand GIBCO Cat# 10091148
RPMI 1640 Medium GIBCO Cat# 11875119
Eptifibatide acetate Santa Cruz Biotechnology Cat# sc-205675
Prostaglandin I2 (PGI2) Cayman Chemical Company Cat# 18220
Triton X-100 ICN Biomedicals Cat# 807426
Luria Bertani Broth medium (LB) Neogen Acumedia Cat# 7290A
Agar BritaniaLab Cat# B0101406
EGM-2 Endothelial Cell Growth Medium-2 BulletKit Lonza Cat# CC-3162
Normal Goat Serum ThermoFisher Cat# O16201
Critical Commercial Assays
EasySep Human CD14 Positive Selection Kit StemCell Technologies Cat# 18058
Human IL-6 ELISA Ready-Set-Go! eBioscience Cat# 88-7066; RRID:AB_2574993
Human IL-10 ELISA Ready-Set-Go! eBioscience Cat# 88-7106; RRID:AB_2575001
Human TNF alpha ELISA Ready-Set-Go! eBioscience Cat# 88-7346; RRID:AB_2575093
FITC Annexin V Apoptosis Detection Kit I BD Biosciences Cat# 556547
Software and Algorithms
GraphPad Prism GraphPad Software Inc. RRID:SCR_002798
FlowJo FlowJo LLC. RRID:SCR_008520
FIJI ImageJ NIH RRID: SCR_002285
illustrator Adobe RRID:SCR_010279
Please cite this article in press as: Carestia et al., Platelets Promote Macrophage Polarization toward Pro-inflammatory Phenotype and Increase Sur-
vival of Septic Mice, Cell Reports (2019), https://doi.org/10.1016/j.celrep.2019.06.062LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for reagents may be directed to and will be fulfilled by the Lead Contact, Eugenio Antonio Carrera
Silva (carrerasilva@yahoo.com.ar).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Study subjects
Anti-coagulated blood samples were obtained frommale and female healthy volunteer donors (age range: 23-58with average of 36.7
years old) who had not taken any non-steroidal anti-inflammatory drugs for 10 days prior to sampling. This studywas approved by the
Institutional Ethics Committee, National Academy of Medicine, Argentina. Written consent was obtained from all subjects.
Mice
Eight- to ten-week-old male and female C57BL/6 (B6) mice were provided by the animal facility of IMEX and maintained in a specific
pathogen-free environment (SPF). Animals were purchased fromCharles River and they were breed in our animal facilities for several
generations. These animals are tested every 6months at Charles River for SPF. All miceweremaintained under a strict 12 h light cycle
(lights on at 7:00 a.m. and off at 7:00 p.m.), and given food and water available ad libitum.
Mouse experiments were performed according to the National Institutes of Health guidelines with the approval of the Institutional
Animal Care and Use Committee (CICUAL) at IMEX.Cell Reports 28, 1–13.e1–e5, July 23, 2019 e2
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Blood sample and purification of human monocytes
Peripheral blood mononuclear cells (PBMCs) were isolated through Ficoll-Hypaque (GE) density gradient centrifugation, as
described previously (Carrera Silva et al., 2013). CD14+monocytes were isolated from PBMCs by an EasySep Human CD14 Positive
Selection Kit (StemCell Tech, Vancouver, Canada).
Preparation of human platelets
Bloodwas drawn into plastic tubes containing sodium citrate (3.8%). Platelet-rich plasma (PRP) was obtained by centrifugation of the
blood samples (200 3 g for 10 min). For washed platelet (WP) suspensions, PRP was treated with prostacyclin (PGI2, 75 nM) and
centrifuged (900 3 g for 10 min), and the platelets were washed in washing buffer (140 mM NaCl, 10 mM NaHCO3, 2.5 mM KCl,
0.5 mM Na2HPO4, 1 mM MgCl2, 22 mM sodium citrate, 0.55 mM glucose, pH 6.5). Finally, the platelets were resuspended in
RPMI supplemented with 10% FBS and 1% penicillin streptomycin (PS) (RPMI/FBS/PS) and kept at room temperature (RT) until
the experiment was performed.
In some experiments, platelets were pre-incubated with aspirin (0.5 mM) and then washed in the presence of PGI2 to remove
excess aspirin.
Monocyte-platelet co-culture
CD14+ monocytes (2x105) were seeded in 48-well flat-bottom plates, and washed platelets (2x107) were added for co-culture con-
ditions. Stimulation was performed with different concentrations of LPS for 24 h, 48 h or 5 days.
Cytokine levels were evaluated in supernatants after 24 and 48 h of co-culture by ELISA.
Macrophages were harvested after 5 days of differentiation and polarization for phenotypic analysis or functional assays. Pheno-
typic characterization of macrophages was achieved by surface staining of CD11b, CD64, CD163, CD206 and CD14. Bacterial
phagocytosis and cell migration into the wounded area were used as functional assays. E. coli expressing green fluorescent protein
(GFP) (GFP-E. coli) was employed for phagocytosis assay and supernatant of re-stimulatedmacrophages (PMA for 4h) was added for
scratched assay (Mena et al., 2014). Intracellular staining of cytokines (TNFa, IL-6 and IL-10) was determined after 24 h of monocyte-
platelets co-culture by flow cytometry and confocal fluorescence microscopy.
Blocking experimental conditions in monocyte-platelet co-cultures
Co-cultures were carried out in a humidified incubator at 37C with CO2 (5%). In some experiments, the co-culture was incubated
with anti-glycoprotein (GP) Ib, clone HIP1, (20 mg/ml); eptifibatide (20 mg/ml); annexin V (2.5 mg/ml); anti-CD11b, clone M1/70,
(10 mg/ml); heparin (5 U/mL) or rabbit IgG anti-human PF4 (2 mg/ml). Cell contact dependence was analyzed using a Transwell
24-System with 0.4 mm pores (Transwell COSTAR, Corning, Merck, Darmstadt, Germany). AXL and TYRO3 receptors on monocytes
were blocked for 1 h before the co-culture. After washing, the platelets were added to the monocytes and stimulated with LPS. Su-
pernatants were collected 24 and 48 h after LPS stimulation, and macrophages were harvested after 5 days of differentiation and
polarization for phenotypic analysis or functional assays. Cell harvesting was performed by a 20-min incubation with PBS/2%
FBS and 1 mM EDTA on ice. The harvested cells were washed once with PBS/2% FBS.
Cytokine levels
Supernatants from the co-cultures were collected after 24 (TNF-a and IL-6) or 48 h (IL-10), centrifuged and stored at 80C until
cytokines were measured using commercial ELISA kits (eBioscience, Ready Set Go).
Surface and intracellular staining and flow cytometry analysis
The surface staining for APCCy7-CD11b, APC-CD64, PercP/Cy5.5-CD163, AF488-CD206 and PECy7-CD14 (phenotypic character-
ization of macrophages) was performed following standard protocol. Briefly, the harvested cells were washed with PBS and blocked
in PBS/2% FBS on ice for 30 min. The cells were washed with PBS and the respective Abs cocktails (prepared in PBS/2% FBS) were
added to the cell pellet and incubated for 30 min on ice. A fixable viability dye was used according to the manufacturer’s instructions
to gate on live cells. After washing, the cells were fixedwith a Cytofix/Cytoperm Kit (BD Biosciences), washed again and analyzed in a
FACS Canto I (Becton Dickinson). All analysis was carried out with FlowJo software (Tree Star). AXL and MERTK expression
were evaluated after fixation and permeabilization (Cytofix/Cytoperm Kit) using biotin-conjugated goat anti-human AXL and APC
anti-human MERTK mAb IgG1 from R&D. PE-Streptoavidin (Biolegend) was used as detection signal for AXL.
For intracellular staining of TNF-a in monocytes, cells were re-stimulated with ionomycin (1 mg/ml) plus PMA (50 nM) and GolgiStop
for an additional 4 h. The cells were then harvested, fixed, permeabilised (Cytofix/Cytoperm Kit) and stained with a PE-conjugated
antibody (Ab) against TNF-a. PE Mouse IgG1 k Isotype Ctrl clone MOPC-21 were used.e3 Cell Reports 28, 1–13.e1–e5, July 23, 2019
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To determine the presence of TNF-a inside platelets or bound to the platelet surface, after 24 h of co-culture, platelets were removed
by the addition of 10mMEDTA for 1min. The platelets were centrifuged and stained with a PE-conjugated Ab against TNF-a accord-
ing to the protocol for surface and intracellular staining.
Bacterial phagocytosis
E. coli DH5a expressing green fluorescent protein (GFP) (GFP-E. coli) were grown at 37C under aerobic conditions with shaking in
Luria Bertani medium overnight. When the bacterial culture reached an OD of 0.6 (spectrophotometry), bacteria were added to the
macrophage cultures (1:2500 v/v) and incubated for 1 h at 37C. Then, the macrophages were washed, fixed and analyzed by flow
cytometry.
HUVEC isolation and cell migration into the wounded area
Umbilical cords were collected from healthy donors. All individuals provided written informed consent for the collection of samples
and subsequent analysis. Primary HumanUmbilical Vein Endothelial Cells (HUVEC) were obtained from human umbilical cord vein by
digestion with collagenase type I and characterize by the presence of Weibel–Palade bodies and the combined expression of endo-
thelial markers (Mena et al., 2014). The cells were grown in a T25 flask previously coated with gelatin 2% and cultured in EGM2.
HUVEC were used between second and fourth passages for experiments.
For the healing assay, after 5 days of co-culture, macrophages were re-stimulated with PMA for 4 h. The supernatants were
collected, centrifuged and added to confluent HUVEC monolayers that had been scratched. The extent of cell migration into the
wounded area was measured after 6 h (Mena et al., 2014).
Fluorescence Imaging
CD14+ monocytes were seeded in 48-well plates containing a glass slide on the bottom, co-cultured with platelets (1:100) and stim-
ulated with LPS. After 24 h, the cells were fixed in 4% PFA for 10 min, washed and permeabilised with 0.1% Triton X-100 for 10 min.
The slides were washed and blocked using blocking buffer (3% of goat serum in PBS). Biotin-conjugated rat anti-human IL-6 (clone
MQ2-39C3) or IL-10 (clone JES3-12G8) or mouse anti-human-TNFa (Mab11) was used for cytokine determination. Primary Abs
against the cytokines were incubated in blocking buffer for 60 min and then washed 3 times. Dylight 649-Streptoavidin (Biolegend)
was used as detection signal and incubated for 60 minutes. After 3 washes, the platelets were labeled with mouse anti-human
PE-CD41 (BD Bioscience). After 3 washes, the slides were mounted and analyzed by confocal fluorescence microscopy using an
FV-1000 microscope (Olympus, Tokyo, Japan).
In vivo sepsis models
Sepsis model was induced in male mice by intraperitoneal (ip) injection of 1x109 GFP-E. coli per mouse in 200 mL of PBS (adapted
from Xiang et al., 2013), which results in a 50% of mortality at 24 h and 80% at 48h post injection. The inoculation amount of E. coli
was established by dose-response assay. After the injection of bacteria, survival was assessed every 4 h for 48 h. All surviving mice
were euthanised at the end of the 2nd day.
In selected experiments cecal ligation and puncture (CLP) sepsis model was used. Briefly, high-grade sepsis was induced by 75%
of cecal ligation with one puncture using 25G needle, adapted from Rittirsch et al. (2009). Under this condition more than 80% of
mortality was observed after 5 days of surgery. Sham animals underwent exactly to the same procedures except for the CLP.
Platelet preparation
Orbital blood from Avertin-anesthetised mice was drawn into plastic tubes containing 10% by volume 3.8% citrate. The anticoagu-
lated blood was diluted 1: 1 in PBS/citrate 0.38% and platelet rich plasma (PRP) was obtained by centrifugation (5 minutes [min] at
100 g at room temperature [RT]). Washed platelets (WP) were obtained by centrifuging PRP (5 min at 200 g at RT) in the presence of
PGI2 (75 ng/ml) and EDTA (2mM) to avoid platelet activation. After washing,WPwere re-suspended in RPMI andmaintained at RT for
30 min prior to transfusion (0.25x109/150 ul/mice injected into the retro-orbital plexus) (Rivadeneyra et al., 2015).
Haematological analysis
Platelets and white cell counts were performed using an Abacus Junior Vet veterinary automated analyzer (Vienna, Austria).
Analysis of macrophages phenotype in spleen
A splenocyte suspension was obtained by mechanical separation employing a 60 mmmesh. After centrifugation, erythrocytes were
lysed with hypotonic buffer, and after washing, the splenocytes (5x106) were blocked and stained for PercP/Cy5.5-CD11b, APCCy7-
F4/80, and AF647-CD206 for 30 min on ice. Then, to determine intracellular iNOS and arginase, the cells were washed, fixed and
permeabilised with the Cytofix/Cytoperm Kit (BD Bioscience). After 30 min of incubation with Abs (PE/Cy7 anti-mouse iNOS and
PE anti-mouse/human Arginase-1) the cells were washed and analyzed in a Partec-Sysmex CyFlow flow cytometer (Go¨rlitz,
Germany).Cell Reports 28, 1–13.e1–e5, July 23, 2019 e4
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Blood samples were obtained by ocular bleeding at the endpoint of the experiment. Plasma was separated by centrifugation
(2500 rpm for 15min), and red blood cells were lysed to obtain total leukocytes. The cells were fixedwith 1%PFA, and the percentage
of GFP-E. coli was evaluated directly in the total leukocytes by flow cytometry.
Blockade of CD11b and GPIb in mice
In vivo blockade of cellular contact mediated by CD11b and GPIb was performed by using anti-CD11b (clone 5C6, Thermo Fisher)
and anti-GPIb (Emfred, Novus Biologicals) antibodies. Briefly, 100ug of anti-CD11b (5C6) antibody was injected intravenously (iv) per
mouse, 1 h before E. coli infection and platelet transfusion. In other experiments, anti-GPIb (20 mg/ml) was added to washed platelets
30 minutes before transfusion, washed again and then transfused by retro-orbital injection. Animals receiving the same amount of
isotype iv or platelets treated with isotype were used as controls.
QUANTIFICATION AND STATISTICAL ANALYSIS
In vitro
Data are expressed as the mean ± SEM. Significant differences between groups were determined using the two-tailed paired
Student’s t test, one-way ANOVA with the Tukey multiple comparison or Fisher LSD test or two-way ANOVA with the Fisher LSD
test was performed. Bartlett’s test for equal variances was also performed.
In vivo
One-way ANOVA with the Fisher LSD test was performed to compare E. coli-infected mice and infected animals that had also
received a platelet transfusion. Survival was compared using the Kaplan-Meier method, followed by the log-rank test. Statistical sig-
nificance was set at p < 0.05.e5 Cell Reports 28, 1–13.e1–e5, July 23, 2019
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Supplementary figure 1. Cytokine measurement in monocytes and platelets, Related to Figure 1. 
 A) Representative dot plot showing intracellular TNF-α staining in cells pre-gated as monocytes after 24 
h of culture in the presence or absence of platelets and LPS stimulation (1ng/ml). B) Gating strategy 
showing FSC vs SSC in log scale and TNF-α staining in platelets after 24 h of been co-cultured with 
monocyte stimulated or not with 1ng/ml of LPS. C) Monocytes were cultured and stimulated with LPS for 
24 or 48 h and then platelets were added for an additional 24 h. TNF-α and IL-6 were measured in the 





Supplementary figure 2. Early platelet-monocyte interaction is needed to induce pro-
inflammatory macrophage, Related to Figure 3. (A) Kinetic of platelets bound to the cell surface (non 
permeabilised cells) or located inside of monocytes (permeabilised cells) during differentiation and 
polarisation of macrophage. Data represent the percentage of monocytes with CD41+ platelets 
associated to the surface (white box and circle) or inside of monocytes (black box and circle) after 12, 
24, 48, 72 and 96 h of initial co-culture. N=3. B) Platelets were removed from monocyte co-culture after 
24 h of starting, by washing, and monocyte-derived macrophages (M-DM) or monocyte/platelet-derived 
macrophages (M/P-DM) were analysed after 5 days of culture using the phenotype markers CD64, 
CD206 and CD163. C) Monocytes were cultured and stimulated with LPS for 24 or 48 h; then platelets 
were added and cultured together for additional 3 days. Macrophages were harvested at day 5 and 
phenotype markers were analysed by flow cytometry. One way ANOVA with the Tukey multiple 






Supplementary figure 3. Pre-treatment of platelets with heparin or blocking PF4 partially reverses 
the effect of platelets on macrophage polarization, Related to Figure 3. (A-E) The platelets were 
pre-treated with ASA (0.5 mM), washed and then added to monocyte cultures. Alternatively, heparin (5 
U/ml) was added to the co-culture and phenotype and functional analyses were performed on day 5 on 
monocyte-derived macrophages (M-DM) and monocyte/platelet-derived macrophages (M/P-DM). (F-H) 
A specific blocking anti-PF4 antibody was added to the platelet-monocyte co-culture, and the 
macrophage phenotype was analysed after 5 days. n=4, one-way ANOVA with the Tukey multiple 







Supplementary figure 4. Resting platelets express protein S (PROS1) and expose 
phosphatidylserine (PtSer) after activation, Related to Figure 4. (A) PROS1 was evaluated on the 
surface or intracellularly in resting platelets using FITC anti-human PROS1 (PS7). The percentage of 
PROS1+ platelets is graphed. (B) PtSer exposure was evaluated in LPS-stimulated (1 µg/ml) platelets 
after 30 min using FITC-Annexin V kit  and the fold induction is shown. n=4, Two-tailed, paired Student’s 





Supplementary figure 5. Sepsis and platelets transfusion validation, Related to Figure 5. A) 
Hematological analysis was performed at different time point after infection and % and absolute number 
of granulocytes and lymphocytes are graphed. Septic animals were followed up for 48 h or until animal 
decease (n=4). B) Plasma concentrations of alanine and aspartate aminotransferase enzymes (ALT and 
AST), Lactate dehydrogenase (LDH) and Creatine kinase in septic mice (n=8) during the first 24h of 
infection with 109 E. coli and compared to non-infected control mice (n=11). C) Histo-pathological 
sections of liver and lung from control and septic mice are shown. Spread inflammatory foci are found in 
E. coli infected mice compared to control mice in both tissues analysed (n=5). D) Platelet transfusion 
efficiency. Mouse platelets were isolated and labelled with CFSE and then transfused by retororbital 
injection. Circulating CFSE-label platelets were measured after 20, 40, 60, 120 y 240 minutes post 
transfusion by flow cytometer (n=4) and compared to 0 (previous transfusion). Results represent the 
mean ±SEM. One-way ANOVA with the Tukey multiple comparison test were used in A and D. Two-







Supplementary figure 6. Platelet transfusion increases survival and induces pro-inflammatory 
macrophage in a CLP model of sepsis, Related to Figure 5. A) Survival curve of CLP mice (N=12) 
compared to CLP plus transfused platelets (N=9) and sham (N=3) mice after 5 days of the chirurgical 
procedure. B) Platelets number was analyzed after 48h of surgery by submandibular bleeding. C) 
Representative dot plot showing spleen macrophages gate based on F4/80 high expression and CD11b 
high or low. D) Representative dot plots showing iNOS and Arginase expression after gating on F4-
80highCD11bhigh and F4-80highCD11blow macrophages. Independent data are shown on the side of dot 
plots. Survival was compared using the Kaplan-Meier method, followed by the log-rank test. One-way 
ANOVA with the Fisher LSD test was used to compare Sham, CLP and CLP plus platelets. Statistical 
significance was set at p<0.05. *p<0.05, **p<0.01 and ***p<0.001.   
